OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia
Khaled A. Elsaid, Tony R. Merriman, Leigh‐Ana Rossitto, et al.
Arthritis & Rheumatology (2022) Vol. 75, Iss. 5, pp. 794-805
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 32

The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies
Megan Leask, Tania O. Crişan, Aichang Ji, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 8, pp. 510-523
Closed Access | Times Cited: 14

Synovial fluid analysis: Relevance for daily clinical practice
Francesca Oliviero, Brian F. Mandell
Best Practice & Research Clinical Rheumatology (2023) Vol. 37, Iss. 1, pp. 101848-101848
Open Access | Times Cited: 14

Herbal remedies in the management of hyperuricemia and gout: A review of in vitro, in vivo and clinical evidences
Mohamad Fawzi Mahomoodally, Kaisavadee Coodian, Muzzammil Hosenally, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3370-3400
Closed Access | Times Cited: 5

Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4)
Marwa Qadri
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1425-1425
Open Access | Times Cited: 11

Gut-immunity-joint axis: a new therapeutic target for gouty arthritis
Pei‐Jer Chen, Zhiqiang Luo, Chengyin Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4

Single-cell transcriptomic analysis identifies VAV3 as a critical regulator of macrophage function in gouty arthritis
Fang Liu, Weizhen Weng, Zuoyu Hu
Research Square (Research Square) (2025)
Closed Access

The inflammation process of gout arthritis and its treatment
Nita Parisa, Muhammad Totong Kamaluddin, Masagus Irsan Saleh, et al.
Journal of Advanced Pharmaceutical Technology amp Research (2023) Vol. 14, Iss. 3, pp. 166-170
Open Access | Times Cited: 8

Contributions of joint damage-related events to gout pathogenesis: new insights from laboratory research
Hanlin Xu, Hengwei Qin, Yinghui Hua, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1511-1515
Closed Access | Times Cited: 7

Novel Genetic Loci in Early‐Onset Gout Derived From Whole‐Genome Sequencing of an Adolescent Gout Cohort
Aichang Ji, Yang Sui, Xiaomei Xue, et al.
Arthritis & Rheumatology (2024) Vol. 77, Iss. 1, pp. 107-115
Closed Access | Times Cited: 2

Pipeline Therapies for Gout
Kevin Yip, Genna Braverman, Linda Yue, et al.
Current Rheumatology Reports (2023) Vol. 26, Iss. 3, pp. 69-80
Closed Access | Times Cited: 6

Gout Basic Research: 2023 in Review
Maria Muntiu, Leo A. B. Joosten, Tania O. Crişan
Gout Urate and Crystal Deposition Disease (2024) Vol. 2, Iss. 3, pp. 220-235
Open Access | Times Cited: 1

Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators
Concepcion Sanchez, Anaamika Campeau, Ru Liu‐Bryan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Novel genetic loci in adolescent-onset gout derived from whole genome sequencing of a Chinese cohort
Aichang Ji, Yang Sui, Xiaomei Xue, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

A structural and functional comparison between two recombinant human lubricin proteins: Recombinant human proteoglycan-4 (rhPRG4) vs ECF843
Nikhil G. Menon, Adam P. Tanguay, Libo Zhou, et al.
Experimental Eye Research (2023) Vol. 235, pp. 109643-109643
Open Access | Times Cited: 2

The Evolving Landscape of Gout in the Female: A Narrative Review
Jennifer Lee, Nicholas A. Sumpter, Tony R. Merriman, et al.
Gout Urate and Crystal Deposition Disease (2023) Vol. 2, Iss. 1, pp. 1-16
Open Access | Times Cited: 2

Sustained xanthine oxidase inhibitor treat to target urate lowering therapy rewires a tight inflammation serum protein interactome
Concepcion Sanchez, Anamika Campeau, Ru Liu‐Bryan, et al.
Research Square (Research Square) (2024)
Open Access

Proteoglycan 4 (Lubricin) and Regulation of Xanthine Oxidase in Synovial Macrophage as A Mechanism of Controlling Synovitis
Khaled A. Elsaid, Ling X. Zhang, Thomas Zhao, et al.
Research Square (Research Square) (2024)
Closed Access

Analysis of the Efficacy and Safety of Benzbromarone Combined with Sodium Bicarbonate Tablets in the Treatment of Hyperuricemia
Weihong Zhu, Keke Huang, Xinyi Zhang, et al.
British Journal of Hospital Medicine (2024) Vol. 85, Iss. 11, pp. 1-12
Closed Access

Proteoglycan 4 (Lubricin) and regulation of xanthine oxidase in synovial macrophage as a mechanism of controlling synovitis
Khaled A. Elsaid, Ling X. Zhang, Thomas Zhao, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access

Proteoglycan 4 (PRG4)/Lubricin and the Extracellular Matrix in Gout
Khaled A. Elsaid, Gregory D. Jay, Ru Liu‐Bryan, et al.
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 3, pp. 122-136
Open Access | Times Cited: 1

The Evolving Landscape of Gout in the Female: A Narrative Review
Jennifer Lee, Nicholas A. Sumpter, Tony R. Merriman, et al.
(2023)
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top